Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2005
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688576A Thiophene compounds
10/26/2005CN1688571A Substituted heterocyclylpyrimidines
10/26/2005CN1688552A Pyrimidine derivatives and their use as CB2 modulators
10/26/2005CN1688550A 2, 5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688194A 2, 4, 5-trisubstituted imidazoles and their use as anti-microbial agents
10/26/2005CN1224622C Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
10/25/2005US6958358 Inhibitors of cruzipain and other cysteine proteases
10/25/2005US6958353 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
10/25/2005US6958349 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/25/2005US6958346 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
10/25/2005US6958339 Pyrazole derivative
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005US6958328 5H-indeno(1,2-b)pyridine-3-carboxylic acid,4-phenyl-2-amino-5-oxo-, ethyl ester; adenosine receptor antagonists, phosphodiesterase inhibitors; neurodegenerative disorders, AIDS; antiinflammatory agent
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2261725C Piperidine and piperazine derivatives and their use as muscarinic antagonists
10/25/2005CA2059882C Sulfonylureas
10/20/2005WO2005097791A1 Inhibitors of iap
10/20/2005WO2005097782A1 Piperidine derivative
10/20/2005WO2005097781A1 Quinines-4-substituted derivatives, method and intermediates for the preparation thereof and pharmaceutical compositions containing said derivatives
10/20/2005WO2005097780A1 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase
10/20/2005WO2005097774A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
10/20/2005WO2005097758A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005WO2005097750A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005WO2005097746A2 2-propene-1-ones as hsp 70 inducers
10/20/2005WO2005097136A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005WO2005097116A1 Composition comprising a jnk inhibitor and cyclosporin
10/20/2005WO2005097107A2 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005046590A3 Methods for synthesizing quinolinone compounds
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005US20050234244 Synthesis of COX-2 and FAAH inhibitors
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234101 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
10/20/2005US20050234098 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally
10/20/2005US20050234083 Diamino-pyrimidines and their use as angiogenesis inhibitors
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234057 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof
10/20/2005US20050234055 Pyrazole derivative
10/20/2005US20050234048 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
10/20/2005US20050234044 Cyclic amine derivatives and methods of use
10/20/2005US20050234042 Organic compounds
10/20/2005US20050234030 Modulators of CRTH2, COX-2 and FAAH
10/20/2005CA2567574A1 Benzotriazine inhibitors of kinases
10/20/2005CA2562399A1 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005CA2561967A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
10/20/2005CA2561907A1 Composition comprising a jnk inhibitor and cyclosporin
10/20/2005CA2561280A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005CA2560954A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005CA2560796A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005CA2560649A1 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase
10/20/2005CA2560162A1 Inhibitors of iap
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586565A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585728A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
10/19/2005EP1585727A1 Indoles useful in the treatment of androgen-receptor related diseases
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1585517A1 Use of substituted 2-phenylbenzimidazoles as medicaments
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP0966446B1 Bicyclic inhibitors of protein farnesyl transferase
10/19/2005CN1685232A Novel fluorescent label compounds
10/19/2005CN1684960A Delta1 pyrrolines used as pesticides
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684955A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/19/2005CN1684948A Cytotoxic agents containing novel potent taxanes and their therapeutic use
10/19/2005CN1223593C Preparation process of Leiliqusai
10/19/2005CN1223592C Bipyridine diaryl ethylene compounds and preparation and application thereof
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005CA2329075C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
10/18/2005CA2295063C Indole compounds as anti-inflammatory/analgesic agents
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2117511C N-cyanoaryl-nitrogen heterocycles
10/13/2005WO2005095440A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
10/13/2005WO2005095392A1 Silylated carboxamides
10/13/2005WO2005095387A1 Tricyclic pyrazole kinase inhibitors
10/13/2005WO2005095386A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005WO2005095384A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095359A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/13/2005WO2005095357A2 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005WO2005095354A1 Therapeutic agents
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 523